Dietary supplement usage by patients with cancer undergoing chemotherapy: Does prognosis or cancer symptoms predict usage?

Journal of Supportive Oncology

Volumn 5, Issue 4, 2007, Pages 195-198

  Bardia, Aditya ^a   Greeno, Edward ^b   Bauer, Brent A ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHONDROITIN; ECHINACEA EXTRACT; FISH OIL; GARLIC EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; PHYTOESTROGEN; VITAMIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PILOT STUDY; PREDICTION; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; BREAST TUMOR; COMPARATIVE STUDY; GASTROINTESTINAL TUMOR; MIDDLE AGED; NEOPLASM; UTILIZATION REVIEW;

ADULT; AGED; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS;

EID: 34250204940     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 2004;104:942-950. [15175592]
2. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998;83:777-782. [9708945]
3. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;27:1-19. [15188733]
4. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-286. [15710790]
5. National Marketing Institute. Dietary Supplements. In: The 2005 Health & Wellness Trends Report. Harleysville, Pa: National Marketing Institute; 2005.
6. Pub Law No. 103-417. 103rd Congress. Dietary Supplement Health and Education Act of 1994. October 25, 1994.
7. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514. [10893280]
8. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-2503. [15197212]
9. Angell M, Kassirer JP. Alternative medicine - the risks of untested and unregulated remedies. N Engl J Med 1998;339:839-841. [9738094]
10. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61:2163-2175. [11772128]
11. Lengacher CA, Bennett MP, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 2002;29:1445-1452. [12432415]
12. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002;20(suppl 18):34S-38S. [12235222]
13. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18:2515-2521. [10893281]
14. Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 2003;62:849-853. [14624907]
15. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur Urol 2003;43:604-608. [12767359]
16. Barqawi A, Gamito F, O'Donnell C, Crawford ED. Herbal and vitamin supplement use in a prostate cancer screening population. Urology 2004;63:288-292. [14972473]
17. Scott JA, Kearney N, Hummerston S, Molassiotis A. Use of complementary and alternative medicine in patients with cancer: a UK survey. Eur J Oncol Nurs 2005;9:131-137. [15944106]
18. Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005;23:2645-2654. [15728227]
19. Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary/ alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 2003;116:U296. [12601420]
20. Bernstein BJ, Grasso T. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park) 2001;15:1267-1272. [11702957]
21. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16:655-663. [15699021]
22. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004;22:4810-4815, [15570083]
23. Rafferty AP, McGee HB, Miller CE, Reyes M. Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 2002;92:1598-1600. [12356602]
24. Morris KT, Johnson N, Homer L, Waits D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 2000;179:407-411. [10930491]
25. Sood A, Moynihan TJ. Cancer-related fatigue: an update. Curr Oncol Rep 2005;7:277-282. [15946587]